BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loid P, Mustila T, Mäkitie RE, Viljakainen H, Kämpe A, Tossavainen P, Lipsanen-Nyman M, Pekkinen M, Mäkitie O. Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity. Front Endocrinol (Lausanne) 2020;11:81. [PMID: 32153512 DOI: 10.3389/fendo.2020.00081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Gala K, Ghusn W, Fansa S, Abu Dayyeh BK, Ghanem OM, Kellogg T, Acosta A. Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Transoral Outlet Reduction After Roux-en-Y Gastric Bypass: A Case-Control Study and Review of Literature. Obes Surg 2023. [PMID: 36708466 DOI: 10.1007/s11695-023-06462-0] [Reference Citation Analysis]
2 Šket R, Kotnik P, Bizjan BJ, Kocen V, Mlinarič M, Tesovnik T, Debeljak M, Battelino T, Kovač J. Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity. Front Endocrinol 2022;13:832911. [DOI: 10.3389/fendo.2022.832911] [Reference Citation Analysis]
3 Loid P, Pekkinen M, Mustila T, Tossavainen P, Viljakainen H, Lindstrand A, Mäkitie O. Targeted Exome Sequencing of Genes Involved in Rare CNVs in Early-Onset Severe Obesity. Front Genet 2022;13:839349. [PMID: 35330733 DOI: 10.3389/fgene.2022.839349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zug R. Developmental disorders caused by haploinsufficiency of transcriptional regulators: a perspective based on cell fate determination. Biol Open 2022;11:bio058896. [PMID: 35089335 DOI: 10.1242/bio.058896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Toumba M, Fanis P, Vlachakis D, Neocleous V, Phylactou LA, Skordis N, Mantzoros CS, Pantelidou M. Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity. Int J Mol Med 2022;49:10. [PMID: 34821371 DOI: 10.3892/ijmm.2021.5065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Serafine KM, O'Dell LE, Zorrilla EP. Converging vulnerability factors for compulsive food and drug use. Neuropharmacology 2021;196:108556. [PMID: 33862029 DOI: 10.1016/j.neuropharm.2021.108556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Carvalho LML, D'Angelo CS, Mustacchi Z, da Silva IT, Krepischi ACV, Koiffmann CP, Rosenberg C. A novel MYT1L mutation in a boy with syndromic obesity: Case report and literature review. Obes Res Clin Pract 2021;15:124-32. [PMID: 33622623 DOI: 10.1016/j.orcp.2021.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kiseleva A, Meshkov A, Ershova A, Sotnikova E, Ivanova A, Smetnev S, Limonova A, Drapkina O. Obesity genetics: current state of the problem. Profil med 2021;24:89. [DOI: 10.17116/profmed20212412189] [Reference Citation Analysis]
9 Wallis N, Raffan E. The Genetic Basis of Obesity and Related Metabolic Diseases in Humans and Companion Animals. Genes (Basel) 2020;11:E1378. [PMID: 33233816 DOI: 10.3390/genes11111378] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]